vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and DNA X, Inc. (SONM). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $16.2M, roughly 1.4× DNA X, Inc.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs 7.9%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs 9.9%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

ADCT vs SONM — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.4× larger
ADCT
$23.1M
$16.2M
SONM
Growing faster (revenue YoY)
ADCT
ADCT
+28.4% gap
ADCT
36.4%
7.9%
SONM
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
9.9%
SONM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ADCT
ADCT
SONM
SONM
Revenue
$23.1M
$16.2M
Net Profit
$-4.8M
Gross Margin
11.2%
Operating Margin
-77.7%
-24.5%
Net Margin
-29.3%
Revenue YoY
36.4%
7.9%
Net Profit YoY
-89.2%
EPS (diluted)
$0.04
$-4.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
SONM
SONM
Q4 25
$23.1M
Q3 25
$15.8M
$16.2M
Q2 25
$18.1M
$11.2M
Q1 25
$17.4M
$16.7M
Q4 24
$16.9M
$15.3M
Q3 24
$18.0M
$15.0M
Q2 24
$17.0M
$11.5M
Q1 24
$17.8M
$9.1M
Net Profit
ADCT
ADCT
SONM
SONM
Q4 25
Q3 25
$-41.0M
$-4.8M
Q2 25
$-56.6M
$-7.5M
Q1 25
$-38.6M
$458.0K
Q4 24
$-21.6M
Q3 24
$-44.0M
$-2.5M
Q2 24
$-36.5M
$-6.6M
Q1 24
$-46.6M
$-2.9M
Gross Margin
ADCT
ADCT
SONM
SONM
Q4 25
Q3 25
11.2%
Q2 25
7.6%
Q1 25
50.0%
Q4 24
-1.2%
Q3 24
28.2%
Q2 24
25.8%
Q1 24
31.8%
Operating Margin
ADCT
ADCT
SONM
SONM
Q4 25
-77.7%
Q3 25
-196.6%
-24.5%
Q2 25
-244.1%
-60.2%
Q1 25
-163.5%
3.9%
Q4 24
-191.8%
55.3%
Q3 24
-197.4%
-15.8%
Q2 24
-170.5%
-56.2%
Q1 24
-188.3%
-29.5%
Net Margin
ADCT
ADCT
SONM
SONM
Q4 25
Q3 25
-260.1%
-29.3%
Q2 25
-313.2%
-66.8%
Q1 25
-221.8%
2.7%
Q4 24
-141.6%
Q3 24
-244.1%
-16.7%
Q2 24
-214.6%
-57.5%
Q1 24
-261.1%
-31.9%
EPS (diluted)
ADCT
ADCT
SONM
SONM
Q4 25
$0.04
Q3 25
$-0.30
$-4.83
Q2 25
$-0.50
$-0.79
Q1 25
$-0.36
$0.08
Q4 24
$-0.26
$-116.99
Q3 24
$-0.42
$-9.32
Q2 24
$-0.38
$-1.41
Q1 24
$-0.56
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
SONM
SONM
Cash + ST InvestmentsLiquidity on hand
$261.3M
$2.1M
Total DebtLower is stronger
$5.1M
Stockholders' EquityBook value
$-185.8M
$-701.0K
Total Assets
$323.1M
$40.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
SONM
SONM
Q4 25
$261.3M
Q3 25
$234.7M
$2.1M
Q2 25
$264.6M
$2.0M
Q1 25
$194.7M
$2.1M
Q4 24
$250.9M
$5.3M
Q3 24
$274.3M
$9.1M
Q2 24
$300.1M
$9.6M
Q1 24
$234.3M
$9.3M
Total Debt
ADCT
ADCT
SONM
SONM
Q4 25
Q3 25
$5.1M
Q2 25
$2.9M
Q1 25
$2.8M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ADCT
ADCT
SONM
SONM
Q4 25
$-185.8M
Q3 25
$-238.2M
$-701.0K
Q2 25
$-199.2M
$-1.3M
Q1 25
$-238.2M
$-1.1M
Q4 24
$-202.6M
$-5.7M
Q3 24
$-171.9M
$15.3M
Q2 24
$-131.7M
$17.5M
Q1 24
$-194.4M
$19.8M
Total Assets
ADCT
ADCT
SONM
SONM
Q4 25
$323.1M
Q3 25
$289.8M
$40.2M
Q2 25
$321.6M
$36.1M
Q1 25
$272.5M
$36.0M
Q4 24
$322.0M
$39.7M
Q3 24
$349.1M
$49.1M
Q2 24
$371.8M
$45.9M
Q1 24
$308.0M
$42.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
SONM
SONM
Operating Cash FlowLast quarter
$-31.1M
$-7.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
SONM
SONM
Q4 25
$-31.1M
Q3 25
$-29.6M
$-7.0M
Q2 25
$-24.1M
$-4.9M
Q1 25
$-56.3M
$-9.6M
Q4 24
$-21.9M
$-4.5M
Q3 24
$-25.0M
$-417.0K
Q2 24
$-32.8M
$-3.4M
Q1 24
$-44.1M
$-168.0K
Free Cash Flow
ADCT
ADCT
SONM
SONM
Q4 25
Q3 25
Q2 25
Q1 25
$-56.6M
Q4 24
$-21.9M
$-4.5M
Q3 24
$-25.3M
$-554.0K
Q2 24
$-32.9M
$-3.4M
Q1 24
$-44.6M
$-198.0K
FCF Margin
ADCT
ADCT
SONM
SONM
Q4 25
Q3 25
Q2 25
Q1 25
-325.2%
Q4 24
-129.8%
-29.6%
Q3 24
-140.2%
-3.7%
Q2 24
-193.0%
-29.8%
Q1 24
-250.0%
-2.2%
Capex Intensity
ADCT
ADCT
SONM
SONM
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
1.5%
Q4 24
0.5%
0.1%
Q3 24
1.2%
0.9%
Q2 24
0.2%
0.3%
Q1 24
3.0%
0.3%
Cash Conversion
ADCT
ADCT
SONM
SONM
Q4 25
Q3 25
Q2 25
Q1 25
-20.97×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons